
---
title: '创业板连跌四天，赛道股跌跌不休，外资突杀回马枪。主力资金大幅出逃3只热门龙头股，卖出资金超79亿'
categories: 
 - 金融
 - 证券时报网
 - 数据
headimg: 'https://data.stcn.com/djsj/202201/W020220107817098634968.png'
author: 证券时报网
comments: false
date: Fri, 07 Jan 2022 22:37:00 GMT
thumbnail: 'https://data.stcn.com/djsj/202201/W020220107817098634968.png'
---

<div>   
<p>中药板块7日大幅回落。</p><p>本周创业板指四连跌，累计跌幅6.8%，将2021年全年12%涨幅跌去一大半。两市成交连续第6个交易日破万亿。北向资金净买入93.35亿元。</p><p>赛道方面，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300760" code="300760">迈瑞医疗</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300896" code="300896">爱美客</a>等医疗股集体重挫，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300750" code="300750">宁德时代</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300014" code="300014">亿纬锂能</a>等锂电概念股也跌幅居前。<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS601555" code="601555">东吴证券</a>认为，A股连续急跌后，短期有望迎来缓和期，但反弹成色仍需观望。机构拥挤度高的品种仍旧风声鹤唳，机构重仓的权重股接连破位，背后与机构调仓密切相关。<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS601211" code="601211">国泰君安</a>则表示，稳增长成为主线是市场共识，稳增长亟需传统基建表现，新基建强度也将保持。</p><p style="text-align:center"><img data-galleryid data-ratio="0.8779956427015251" data-s="300,640" src="https://data.stcn.com/djsj/202201/W020220107817098634968.png" data-type="png" data-w="459" data-imgqrcoded="1" oldsrc="W020220107817098634968.png" referrerpolicy="no-referrer"></p><p>近期持续活跃的中药板块今日大幅回落，收跌4.18%。成份股中，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300026" code="300026">红日药业</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300519" code="300519">新光药业</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300181" code="300181">佐力药业</a>跌逾11%，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ002349" code="002349">精华制药</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ002750" code="002750">龙津药业</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ002644" code="002644">佛慈制药</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ002412" code="002412">汉森制药</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ002566" code="002566">益盛药业</a>等5股跌停。</p><p>本轮中药板块上涨行情始于去年12月30日，国家中药管理局明确提出将适宜的中药和中医医疗服务项目纳入医保支付范围，强化医保基金监管。政策利好刺激下，近期中药股攻势猛烈。</p><p>消息面上，1月7日，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ002750" code="002750">龙津药业</a>公告，公司控股股东群星投资计划减持股份不超过1201.5万股，占公司总股本3%，实控人樊献俄先生拟减持不超过77.54万股。在本轮中药上涨行情中，最显眼的就是<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ002750" code="002750">龙津药业</a>。该股12月22日-1月5日收获10连板，累计涨幅159.1%。以最新价17.62元/股计算，本次大股东加实控人合计套现约2.25亿元。</p><p style="text-align:center"><img data-galleryid data-ratio="1.336111111111111" data-s="300,640" src="https://data.stcn.com/djsj/202201/W020220107817099135423.jpeg" data-type="jpeg" data-w="1080" data-imgqrcoded="1" width="500px" height="668.0555555555555px" style="width: 500px; height: 668.0555555555555px;" oldsrc="W020220107817099135423.jpeg" referrerpolicy="no-referrer"></p><p>同日，中国中药港交所公告，非执行董事、董事会副主席王晓春先生已以每股5.57港元的价格转让其持有的公司股票1.05亿股，相当于已发行股份的约2.09%，金额约5.85亿港元。港股中医药板块今日同样普跌。</p><p><strong>业绩高增中药概念股来了</strong></p><p><a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS601211" code="601211">国泰君安</a>认为，中药板块相对医药整体的极值折价已显著收敛，整体估值性价比正在逐步消失。行业底层逻辑的变化需得到业绩验证，短期少数公司提价逻辑也将接受验证，或将推动个股分化。另一方面，随着其他业绩高景气赛道正形成估值与景气度的新平衡，也将对中药板块的估值与增长匹配度形成约束。</p><p>证券时报·数据宝统计了机构预计2021年业绩高增的中药概念股名单。行情来看，中药指数自12月20日起单边上行，累计涨幅21.73%。概念股中14股去年12月至今累计涨逾20%，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600566" code="600566">济川药业</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ000999" code="000999">华润三九</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600129" code="600129">太极集团</a>居前，涨幅超过50%，其后<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600976" code="600976">健民集团</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ002873" code="002873">新天药业</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600085" code="600085">同仁堂</a>涨幅落在40%-50%区间。</p><p style="text-align:center"><img data-galleryid data-ratio="1.3811563169164882" data-s="300,640" src="https://data.stcn.com/djsj/202201/W020220107817099686493.png" data-type="png" data-w="467" data-imgqrcoded="1" oldsrc="W020220107817099686493.png" referrerpolicy="no-referrer"></p><p>证券时报·数据宝统计了机构预计2021年业绩高增的中药概念股名单。净利润增长率来看，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ000423" code="000423">东阿阿胶</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600129" code="600129">太极集团</a>和<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600976" code="600976">健民集团</a>幅度居前，分别为973.6%、216.9%和118.12%。截至目前，两股已公告年度业绩预告和增长上限，分别为<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ002317" code="002317">众生药业</a>191.42%、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300181" code="300181">佐力药业</a>110.58%。</p><p>全年净利润增长率方面，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ000423" code="000423">东阿阿胶</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600129" code="600129">太极集团</a>和<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600976" code="600976">健民集团</a>幅度居前，分别为973.6%、216.9%和118.12%。截至目前，两股已公告年度业绩预告和增长上限，分别为<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ002317" code="002317">众生药业</a>191.42%、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300181" code="300181">佐力药业</a>110.58%。</p><p>数据宝统计，中药板块近期估值已升至高位，1月7日为33.79倍。最新滚动市盈率低于这一数值且预计2021年净利润增长率在30%以上的个股仅有5只，分别为<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ002287" code="002287">奇正藏药</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600557" code="600557">康缘药业</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ002603" code="002603">以岭药业</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600329" code="600329">中新药业</a>和<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600566" code="600566">济川药业</a>。其中<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ002287" code="002287">奇正藏药</a>预计业绩增幅最高，为70.82%。</p><p style="text-align:center"><img data-galleryid data-ratio="0.37884378843788435" data-s="300,640" src="https://data.stcn.com/djsj/202201/W020220107817100138394.png" data-type="png" data-w="813" data-imgqrcoded="1" width="500px" height="189.42189421894219px" style="width: 500px; height: 189.42189421894219px;" oldsrc="W020220107817100138394.png" referrerpolicy="no-referrer"></p><p>机构关注度方面，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600436" code="600436">片仔癀</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600535" code="600535">天士力</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600085" code="600085">同仁堂</a>评级数量居前，分别有15家、8家和7家机构参与，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600976" code="600976">健民集团</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ000999" code="000999">华润三九</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ000423" code="000423">东阿阿胶</a>和<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ002390" code="002390">信邦制药</a>的评级机构也均在5家及以上。</p><p><strong>一周主力净流出1356亿元</strong></p><p><strong>医药生物遭大幅减仓</strong></p><p>2021年12月31日至2022年1月7日，一周主力合计净流出1355.85亿元。以申万一级行业划分，通信、银行、家用电器获主力大幅回流，净流入额分别为82.12亿元、34.56亿元、20.22亿元；钢铁和房地产也有10亿元以下资金注入。其余行业则均为净流出状态。医药生物净流出额居首，高达231.55亿元；其后电子、化工、有色金属、公用事业和电气设备净流出额也均逾百亿。</p><p>数据宝统计，除去近一月上市新股，12股净流出额逾10亿元。主力大幅出逃龙头股，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300059" code="300059">东方财富</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ000723" code="000723">美锦能源</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ002594" code="002594">比亚迪</a>净流出资金居前，分别为30.17亿元、25.39亿元、24.07亿元。<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600111" code="600111">北方稀土</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300015" code="300015">爱尔眼科</a>和<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ000858" code="000858">五粮液</a>净流出额也均在15亿元以上。赛道方面，新能源、白酒、医药均有3只及以上个股上榜，白酒板块<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600519" code="600519">贵州茅台</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ000799" code="000799">酒鬼酒</a>净流出额逾9亿元；医药股的<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300015" code="300015">爱尔眼科</a>和<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600436" code="600436">片仔癀</a>净流出额则双双破11亿元。</p><p style="text-align:center"><img data-galleryid data-ratio="1.601010101010101" data-s="300,640" src="https://data.stcn.com/djsj/202201/W020220107817100677693.png" data-type="png" data-w="396" data-imgqrcoded="1" oldsrc="W020220107817100677693.png" referrerpolicy="no-referrer"></p><p>主力净流入方面，随着近期热门成长赛道集体调整，传统价值股开始回归。7日，大基建雄起，万科A、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ000651" code="000651">格力电器</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS601318" code="601318">中国平安</a>齐齐涨逾3%，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600031" code="600031">三一重工</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ000333" code="000333">美的集团</a>等蓝筹股也纷纷大涨，主力竞相抢筹。除了<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ000333" code="000333">美的集团</a>，上述4股均获主力10亿元以上加仓。此外，银行股的<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS601166" code="601166">兴业银行</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS601398" code="601398">工商银行</a>各自获得主力10.8亿元、5.91亿元增持；光伏板块两大巨头<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS601012" code="601012">隆基股份</a>和<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600438" code="600438">通威股份</a>虽然周内走势不佳，但也均获得了5亿元资金的净流入。（数据宝 张智博）</p><p style="text-align: center;"><img data-galleryid data-ratio="1.601010101010101" data-s="300,640" src="https://data.stcn.com/djsj/202201/W020220107817101191036.png" data-type="png" data-w="396" data-imgqrcoded="1" oldsrc="W020220107817101191036.png" referrerpolicy="no-referrer"></p>
  
</div>
            